Promega Hits 100% Renewable Electricity Across Global Operations…

Event summary

Promega achieved 100% renewable electricity across all global operations by July 28, 2026.
Scope 3 emissions account for 76% of the company’s total footprint, highlighting supplier engagement challenges.
SBTi validated Promega’s near-term emissions reduction targets in April 2026.
Promega completed its first comprehensive greenhouse gas inventory across global operations and value chain.

The big picture

Promega’s achievement of 100% renewable electricity underscores a broader industry shift toward sustainability in biotech. The company’s focus on Scope 3 emissions highlights the growing importance of supply chain transparency, particularly as regulatory pressures mount for carbon-neutral operations. With over 4,000 products and global distribution, Promega’s strategy could set a precedent for ESG compliance in life sciences.

What we're watching

Supplier Engagement: How Promega will address the 76% of emissions tied to its value chain, particularly through supplier partnerships.
Target Validation: Whether SBTi-validated targets will drive meaningful long-term reductions in Promega’s carbon footprint.
Industry Benchmarking: The pace at which other life sciences companies adopt similar renewable energy and emissions reduction strategies.